Skip to content
Screener

Operating Income at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$83M+855%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$7.14B+7.4%
Staar Surgical logo
Staar SurgicalSTAA
$7.98M+114%
Ardelyx logo
ArdelyxARDX
-$12.43M+13.7%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$79.31M+75.0%
AbbVie logo
AbbVieABBV
$6.43B+31.4%

Segments

By segment

See full
Salix$468M+26.1%
Bausch + Lomb$277M+53.9%
Diversified$112M-11.8%
International$88M+3.5%
Solta Medical$75M+41.5%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.21B+3.8%
Enterprise value$21.66B-2.1%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Restructuring, integration and separation costs131
Other expense, net3215
3,4741,983
Operating (loss) income(950)276
Interest income1011
Interest expense(402)(330)
Loss on extinguishment of debt(1)
Foreign exchange and other(11)(4)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's operating income?
Bausch Health Companies (BHC) reported operating income of -$950M in Q1 2026.
How has Bausch Health Companies's operating income changed year-over-year?
Bausch Health Companies's operating income decreased by 444.2% year-over-year, from $276M to -$950M.
What is the long-term trend for Bausch Health Companies's operating income?
Over 3 years (2021 to 2025), Bausch Health Companies's operating income has grown at a 59.1% compound annual growth rate (CAGR), from $450M to $1.81B.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

Ask your AI about Bausch Health Companies's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude